TrialJournal of acquired immune deficiency syndromes (1999)2013

Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa.

Kenneth Kintu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.